Skip to main content
SpringerLink
Log in

Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics

  • Protocol
  • First Online:
Liver Carcinogenesis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2769))

Abstract

Liver cancers are characterized by interindividual and intratumoral heterogeneity, which makes early diagnosis and the development of therapies challenging. Desorption electrospray ionization mass spectrometry (DESI-MS) imaging is a potent and sensitive MS ionization technique for direct, unaltered 2D and 3D imaging of metabolites in complex biological samples. Indeed, DESI gently desorbs and ionizes analyte molecules from the sample surface using an electrospray source of highly charged aqueous spray droplets in ambient conditions. DESI-MS imaging of biological samples allows untargeted analysis and characterization of metabolites in liver cancers to identify new biomarkers of malignancy. In this chapter, we described a detailed protocol using liver cancer samples collected and stored for histopathology examination, either as frozen or as formalin-fixed, paraffin-embedded specimens. Such hepatocellular carcinoma samples can be subjected to DESI-MS analyses, illustrating the capacity of spatially resolved metabolomics to distinguish malignant lesions from adjacent normal liver tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Godoy-Matos AF, Silva Junior WS, Valerio CM (2020) NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr 12:60. https://doi.org/10.1186/s13098-020-00570-y

    Article  PubMed  PubMed Central  Google Scholar 

  2. Abd El-Kader SM, El-Den Ashmawy EM (2015) Non-alcoholic fatty liver disease: the diagnosis and management. World J Hepatol 7(6):846–858. https://doi.org/10.4254/wjh.v7.i6.846

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dhamija E, Paul SB, Kedia S (2019) Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern. Indian J Med Res 149(1):9–17. https://doi.org/10.4103/ijmr.IJMR_1456_17

    Article  PubMed  PubMed Central  Google Scholar 

  4. Llovet JM et al (2016) Hepatocellular carcinoma. Nat Rev Dis Primers 2:16018. https://doi.org/10.1038/nrdp.2016.18

    Article  PubMed  Google Scholar 

  5. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6(9):674–687. https://doi.org/10.1038/nrc1934

    Article  PubMed  Google Scholar 

  6. Gong L et al (2019) Cancer cell reprogramming: a promising therapy converting malignancy to benignity. Cancer Commun (Lond) 39(1):48. https://doi.org/10.1186/s40880-019-0393-5

    Article  PubMed  Google Scholar 

  7. Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368(6487). https://doi.org/10.1126/science.aaw5473

  8. Daniele B, Bencivenga A, Megna AS, Tinessa V (2004) Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S108–S112. https://doi.org/10.1053/j.gastro.2004.09.023

    Article  PubMed  Google Scholar 

  9. Nobuoka D et al (2010) Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma. Oncol Rep 24(2):521–528. https://doi.org/10.3892/or_00000888

    Article  PubMed  Google Scholar 

  10. Cillo U et al (2004) The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 40(1):124–131. https://doi.org/10.1016/j.jhep.2003.09.027

    Article  PubMed  Google Scholar 

  11. Lurje I et al (2019) Treatment strategies for hepatocellular carcinoma (−) a multidisciplinary approach. Int J Mol Sci 20(6). https://doi.org/10.3390/ijms20061465

  12. Gosalia AJ, Martin P, Jones PD (2017) Advances and future directions in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 13(7):398–410

    PubMed  Google Scholar 

  13. Smith L et al (2020) Important considerations for sample collection in metabolomics studies with a special focus on applications to liver functions. Meta 10(3). https://doi.org/10.3390/metabo10030104

  14. Ferrarini A et al (2019) Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma. J Proteome Res 18(8):3067–3076. https://doi.org/10.1021/acs.jproteome.9b00185

    Article  PubMed  Google Scholar 

  15. Feng N et al (2022) Metabolomic biomarkers for hepatocellular carcinoma: a systematic review. Medicine (Baltimore) 101(3):e28510. https://doi.org/10.1097/MD.0000000000028510

    Article  PubMed  Google Scholar 

  16. Saoi M, Britz-McKibbin P (2021) New advances in tissue metabolomics: a review. Meta 11(10). https://doi.org/10.3390/metabo11100672

  17. Chan LK, Tsui YM, Ho DW, Ng IO (2022) Cellular heterogeneity and plasticity in liver cancer. Semin Cancer Biol 82:134–149. https://doi.org/10.1016/j.semcancer.2021.02.015

    Article  PubMed  Google Scholar 

  18. Lubin A, Cabooter D, Augustijns P, Cuyckens F (2015) One drop chemical derivatization – DESI-MS analysis for metabolite structure identification. J Mass Spectrom 50(7):871–878. https://doi.org/10.1002/jms.3604

    Article  PubMed  Google Scholar 

  19. Eberlin LS (2014) DESI-MS imaging of lipids and metabolites from biological samples. Methods Mol Biol 1198:299–311. https://doi.org/10.1007/978-1-4939-1258-2_20

    Article  PubMed  Google Scholar 

  20. Dannhorn A et al (2020) Universal sample preparation unlocking multimodal molecular tissue imaging. Anal Chem 92(16):11080–11088. https://doi.org/10.1021/acs.analchem.0c00826

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

GK is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR) – Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Fondation pour la Recherche Médicale (FRM); a donation by Elior; Equipex Onco-Pheno-Screen; European Joint Programme on Rare Diseases (EJPRD); Gustave Roussy Odyssea, the European Union Horizon 2020 Projects Oncobiome and CRIMSON (grant agreement No. 101016923); Fondation Carrefour; Institut National du Cancer (INCa); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); a Cancer Research ASPIRE Award from the Mark Foundation; the RHU Immunolife; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Université de Paris ANR-18-IDEX-0001. HC and SL are supported by the China Scholarship Council (CSC, file n°. 201908070134 and file n° 201907060011, respectively). UN-R is supported by Axudas de apoio á etapa de formación posdoutoral da Xunta de Galicia – GAIN. N°Expediente: IN606B-2021/015.

Conflicts of Interest

GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sotio, Tollys, Vascage, and Vasculox/Tioma. GK has been consulting for Reithera. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics, and Therafast Bio. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis, and metabolic disorders.

Author information

Authors and Affiliations

  1. Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France

    Hui Chen, Sylvère Durand, Mélanie Bourgin, Léa Montégut, Flavia Lambertucci, Omar Motiño, Sijing Li, Uxía Nogueira-Recalde, Gerasimos Anagnostopoulos, Maria Chiara Maiuri, Guido Kroemer & Isabelle Martins

  2. Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France

    Hui Chen, Sylvère Durand, Mélanie Bourgin, Léa Montégut, Flavia Lambertucci, Omar Motiño, Sijing Li, Uxía Nogueira-Recalde, Gerasimos Anagnostopoulos, Maria Chiara Maiuri, Guido Kroemer & Isabelle Martins

  3. Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France

    Hui Chen, Léa Montégut & Sijing Li

  4. PETRA, UMS AMICCa, Gustave Roussy, Villejuif, France

    Olivia Bawa

  5. Rheumatology Research Group (GIR), Biomedical Research Institute of A Coruña (INIBIC), Professor Novoa Santos Foundation, A Coruña, Spain

    Uxía Nogueira-Recalde

  6. Department of Molecular Medicine and Medical Biotechnologies, University of Napoli Federico II, Naples, Italy

    Maria Chiara Maiuri

  7. Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

    Guido Kroemer

Authors
  1. Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvère Durand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olivia Bawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mélanie Bourgin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Léa Montégut
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Flavia Lambertucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omar Motiño
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sijing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Uxía Nogueira-Recalde
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gerasimos Anagnostopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Maria Chiara Maiuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Guido Kroemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Isabelle Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabelle Martins .

Editor information

Editors and Affiliations

  1. Centre de Recherche des Cordeliers, Paris, France

    Guido Kroemer

  2. Centre de Recherche des Cordeliers, Paris, France

    Jonathan Pol

  3. Centre de Recherche des Cordeliers, Paris, France

    Isabelle Martins

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Chen, H. et al. (2024). Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics. In: Kroemer, G., Pol, J., Martins, I. (eds) Liver Carcinogenesis. Methods in Molecular Biology, vol 2769. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3694-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3694-7_15

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3693-0

  • Online ISBN: 978-1-0716-3694-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation